Search

everythinglearnresearchcommunity

for

Search:↓

Dexamethasone mini-pulse therapy is effective for alopecia areata but less effective for those with early onset or hypothyroidism.

Microneedles combined with conventional therapies show promise in treating alopecia areata.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

Brevilin-A is a safe and effective treatment for mild to moderate alopecia areata in children.

Oral Minoxidil could be a safe and effective alternative treatment for various non-androgenic alopecias.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Phototherapy can help treat hair loss in alopecia areata.

JAK inhibitors offer new hope for treating severe alopecia areata.

Voglibose may help treat skin hyperpigmentation safely.

A new microneedle patch effectively promotes hair regrowth with less frequent dosing.

Leflunomide can cause skin ulcers, and stopping it can lead to healing.

Recombinant Human Annexin A5 may help treat localized scleroderma by reducing skin thickening and inflammation.

Microneedles offer a promising, less invasive way to treat and monitor psoriasis.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

The guideline provides recommendations for managing alopecia areata effectively.

A specific gene mutation causes Olmsted syndrome.

Early detection and multidisciplinary management of skin and mouth side effects from breast cancer treatments improve patient outcomes.

The new delivery system improved hair growth in alopecia treatment.

Early intervention and tailored management are crucial for skin side effects in cancer treatments.

Low-dose oral minoxidil might help with hair loss during chemotherapy, but more research is needed.

Biopsy is crucial to correctly diagnose granuloma annulare, which can mimic other conditions like alopecia mucinosa.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

Imiquimod can cause rare skin side effects, some irreversible, and long-term follow-up is important for users.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

New treatments show promise for hair loss, especially JAK inhibitors for alopecia areata.

Older patients with new retinal lesions may have cancer, and local radiation might not stop it from spreading.

Bimatoprost can cause longer, thicker, darker eyelashes and eyebrows.

The document concludes that scalp conditions have various causes and can present in many different ways.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.